Enteral Nutrition with Anti-inflammatory Lipids in ALI/ARDS

  • A. Pontes-Arruda
  • S. J. DeMichele
Conference paper


Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) are two severe forms of respiratory failure characterized by non-cardiogenic pulmonary edema and refractory hypoxemia with massive pulmonary and systemic release of pro-inflammatory mediators. The incidence of these life-threatening pulmonary diseases in the United States is currently estimated at 56–82 cases per 100,000 persons/ year [1, 2]. Current strategies adopted to treat patients with ALI and ARDS, including protective ventilation and prone positioning among others, are supportive in nature and have not shown a clear benefit in terms of mortality reduction [3].


Arachidonic Acid Acute Lung Injury Acute Respiratory Distress Syndrome Enteral Nutrition Intravenous Lipid Emulsion 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Rubenfeld GD, Caldwell E, Peabody E, et al (2005) Incidence and outcomes of acute lung injury. N Engl J Med 353: 1685–1693CrossRefPubMedGoogle Scholar
  2. 2.
    Mutlu GM, Budinger GR (2006) Incidence and outcomes of acute lung injury. N Engl J Med 354: 416–417CrossRefPubMedGoogle Scholar
  3. 3.
    Brower RG, Ware LB, Berthiaume Y, Matthay MA (2001) Treatment of ARDS. Chest 120: 1347–1367CrossRefPubMedGoogle Scholar
  4. 4.
    Bringham KL (1985) Metabolites of arachidonic acid in experimental lung vascular injury. Fed Proc 44: 43–45Google Scholar
  5. 5.
    Henderson WR Jr (1987) Lipid-derivered and other chemical mediators of inflammation in the lung. J Allergy Clin Immunol 79: 543–553CrossRefPubMedGoogle Scholar
  6. 6.
    Mizock BA (2001) Nutritional support in acute lung injury and acute respiratory distress syndrome. Nutr Clin Pract 16: 319–328CrossRefGoogle Scholar
  7. 7.
    Mizock BA, DeMichele SJ (2004) The acute respiratory distress syndrome: role of nutritional modulation of inflammation through dietary lipids. Nutr Clin Pract 19: 563–574CrossRefPubMedGoogle Scholar
  8. 8.
    Pontes-Arruda A (2007) The use of special lipids in the treatment of inflammatory lung disease. Clin Nutr Insight 33: 1–4Google Scholar
  9. 9.
    Mayer K, Schaefer MB, Seeger W (2006) Fish oil in the critically ill: from experimental to clinical data. Curr Opin Clin Nutr Metab Care 9: 140–148CrossRefPubMedGoogle Scholar
  10. 10.
    DeMichele SJ, Wood SM, Wennberg AK (2006) A nutritional strategy to improve oxygenation and decrease morbidity in patients who have acute respiratory distress syndrome. Respir Care Clin N Am 12: 547–566PubMedGoogle Scholar
  11. 11.
    de Alaniz MJ, Marra CA (1992) Glucocorticoid and mineralocorticoid hormones depress liver delta 5 desaturase activity through different mechanisms. Lipids 27: 599–604CrossRefPubMedGoogle Scholar
  12. 12.
    Mills DE, Huang YS, Narce M, Poisson JP (1994) Psychosocial stress, catecholamines, and essential fatty acid metabolism in rats. Proc Soc Exp Biol Med 205: 56–61PubMedGoogle Scholar
  13. 13.
    Palombo JD, DeMichele SJ, Boyce PJ, Noursalehi M, Forse RA, Bistrian BR (1998) Metabolism of dietary alpha-linolenic acid vs eicosapentaenoic acid in rat immune cell phospholipids during endotoxemia. Lipids 33: 1099–1105CrossRefPubMedGoogle Scholar
  14. 14.
    Fan YY, Chapkin RS (1998) Importance of dietary gamma-linolenic acid in human health and nutrition. J Nutr 128: 1411–1414PubMedGoogle Scholar
  15. 15.
    Karlstad MD, DeMichele SJ, Leathem WD, et al (1993) Effect of intravenous lipid emulsions enriched with gamma-linolenic acid on plasma n-6 fatty acids and prostaglandin biosynthesis after burn and endotoxin injury in rats. Crit Care Med 21: 1740–1749CrossRefPubMedGoogle Scholar
  16. 16.
    Johnson MM, Swan DD, Surette ME, et al (1997) Dietary supplementation with gamma-linolenic acid alters fatty acid content and eicosanoid production in healthty humans. J Nutr 127: 1435–1444PubMedGoogle Scholar
  17. 17.
    Wanten GJA, Calder PC (2007) Immune modulation by parenteral lipid emulsions. Am J Clin Nutr 85: 1171–1184PubMedGoogle Scholar
  18. 18.
    Deckelbaum RJ, Worgall TS, Seo T (2006) n-3 Fatty acids and gene expression. Am J Clin Nutr 83 (Suppl): S1520–S1525Google Scholar
  19. 19.
    Singer P, Shapiro H, Theilla M, Anbar R, Singer J, Cohen J (2008) Anti-inflammatory properties of omega-3 fatty acids and critical illness: novel mechanisms and an integrative perspective. Intensive Care Med 34: 1580–1592CrossRefPubMedGoogle Scholar
  20. 20.
    Denys A, Hichami A, Khan NA (2005) n-3 PUFAs modulate T-cell activation via protein kinase C-alpha and —epsilon and the NF-kappaB signaling pathway. J Lipid Res 46: 752–758CrossRefPubMedGoogle Scholar
  21. 21.
    Sperling RI, Benincaso AI, Knoell CT, et al (1993) Dietary omega-3 polyunsaturated fatty acids inhibit phosphoinositide formation and chemotaxis in neutrophils. J Clin Invest 91: 651–660CrossRefPubMedGoogle Scholar
  22. 22.
    Madani S, Hichami A, Cherkaoui-Malki M, Khan NA (2004) Diacylglycerols containing omega-3 and omega-6 fatty acids bind to RasGRP and modulate MAP kinase activation. J Biol Chem 279: 1176–1183CrossRefPubMedGoogle Scholar
  23. 23.
    Chen H, Li D, Chen J, et al (2003) EPA and DHA attenuate ox-LDL-induced expression of adhesion molecules in human coronary artery endothelial cells via protein kinase B pathway. J Mol Cell Cardiol 35: 769–775CrossRefPubMedGoogle Scholar
  24. 24.
    Fialkow L, Fochesatto Filho L, Bozzetti MC, et al (2006) Neutrophil apoptosis: a marker of disease severity in sepsis and sepsis-induced acute respiratory distress syndrome. Crit Care 10: R155CrossRefPubMedGoogle Scholar
  25. 25.
    Annane D, Bellissant E, Cavaillon JM (2005) Septic shock. Lancet 365: 63–78CrossRefPubMedGoogle Scholar
  26. 26.
    Willoughby DA, Moore AR, Colville-Nash PR, Gilroy D (2000) Resolution of inflammation. Int J Immunopharmacol 22: 1131–1135CrossRefPubMedGoogle Scholar
  27. 27.
    Savill JS, Wyllie AH, Henson JE, Walport MJ, Henson PM, Haslett C (1989) Macrophage phagocytosis of aging neutrophils in inflammation. Programmed cell death in the neutrophil leads to its recognition by macrophages. J Clin Invest 83: 865–875CrossRefPubMedGoogle Scholar
  28. 28.
    Haslett C (1992) Resolution of acute inflammation and the role of apoptosis in the tissue fate of granulocytes. Clin Sci (Lond) 83: 639–648Google Scholar
  29. 29.
    Serhan CN, Savill J (2005) Resolution of inflammation: the beginning programs the end. Nat Immunol 6: 1191–1197CrossRefPubMedGoogle Scholar
  30. 30.
    Ward C, Walker A, Dransfield I, Haslett C, Rossi AG (2004) Regulation of granulocyte apoptosis by NF-κB. Biochem Soc Trans 32: 465–467CrossRefPubMedGoogle Scholar
  31. 31.
    Freire-de-Lima CG, Xiao YQ, Gardai SJ, Bratton DL, Schiemann WP, Henson PM (2006) Apoptotic cells, through transforming growth factor-β, coordinately induce anti-inflammatory and suppress pro-inflammatory eicosanoid and NO synthesis in murine macrophages. J Biol Chem 281: 38376–38384CrossRefPubMedGoogle Scholar
  32. 32.
    Lucas M, Stuart LM, Savill J, Lacy-Hullbert A (2003) Apoptotic cells and innate stimuli combine to regulate macrophage cytokine secretion. J Immunol 171: 2610–2615PubMedGoogle Scholar
  33. 33.
    Serhan CN, Clish CB, Brannon J, Colgan SP, Chiang N, Cronert K (2000) Novel functional sets of lipid-derived mediators with anti-inflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal anti-inflammatory drugs and transcellular processing. J Exp Med 192: 1197–1204CrossRefPubMedGoogle Scholar
  34. 34.
    Serhan CN, Hong S, Gronert K, et al (2002) Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. J Exp Med 196: 1025–1037CrossRefPubMedGoogle Scholar
  35. 35.
    Mancuso P, Whelan J, DeMichele SJ, Snider CC, Guszcza JA, Karlstad MD (1997) Dietary fish oil and fish and borage oil suppress intrapulmonary proinflammatory eicosanoid biosynthesis and attenuate pulmonary neutrophil accumulation in endotoxic rats. Crit Care Med 25: 1198–1206CrossRefPubMedGoogle Scholar
  36. 36.
    Mancuso P, Whelan J, DeMichele SJ, et al (1997) Effects of eicosapentaenoic and gammalinolenic acid on lung permeability and alveolar macrophage eicosanoid synthesis in endotoxic rats. Crit Care Med 25: 523–532CrossRefPubMedGoogle Scholar
  37. 37.
    Murray MJ, Kumar M, Gregory TJ, Banks PL, Tazelaar HD, DeMichele SJ (1995) select dietary fatty acids attenuate cardiopulmonary dysfunction during acute lung injury in pigs. Am J Physiol 269: H2090–H2099PubMedGoogle Scholar
  38. 38.
    Murray MJ, Kanazi G, Moukabary K, Tazelaar HD, DeMichele SJ (2000) Effects of eicosapentaenoic and gamma-linolenic acids (dietary lipids) on pulmonary surfactant composition and function during porcine endotoxemia. Chest 117: 1720–1727CrossRefPubMedGoogle Scholar
  39. 39.
    Palombo JD, DeMichele SJ, Lydon E, Bistrian BR (1997) Cyclic vs continuous enteral feeding with omega-3 and gamma-linolenic fatty acids: effects on modulation of phospholipid fatty acids in rat lung and liver immune cells. JPEN J Parenter Enteral Nutr 21: 123–132CrossRefPubMedGoogle Scholar
  40. 40.
    Palombo JD, DeMichele SJ, Boyce PJ, et al (1999) Effect of short-term enteral feeding with eicosapentaenoic and gamma-linolenic acids on alveolar macrophage eicosanoid synthesis and bactericidal function in rats. Crit Care Med 27: 1908–1915CrossRefPubMedGoogle Scholar
  41. 41.
    Palombo JD, DeMichele SJ, Lyndon EE, et al (1996) Rapid modulation of lung and liver macrophage phospholipid fatty acids in endotoxemic rats by continuous Enteral feeding with n-3 and gamma-linolenic fatty acids. Am J Clin Nutr 63: 208–219PubMedGoogle Scholar
  42. 42.
    Gadek JE, DeMichele SJ, Karlstad MD, et al (1999) Effect of enteral feeding with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants in patients with acute respiratory distress syndrome. Enteral nutrition in ARDS study group. Crit Care Med 27: 1409–1420CrossRefPubMedGoogle Scholar
  43. 43.
    Singer P, Theilla M, Fisher H, et al (2006) Benefit of an enteral diet enriched with eicosapentaenoic acid and gamma-linolenic acid in ventilated patients with acute lung injury. Crit Care Med 34: 1033–1038CrossRefPubMedGoogle Scholar
  44. 44.
    Pontes-Arruda A, Aragão AM, Albuquerque JD (2006) The effects of enteral feeding with eicosapentaenoic acid, gamma-linolenic acid and antioxidants in mechanically ventilated patients with severe sepsis and septic shock. Crit Care Med 34: 2325–2333CrossRefPubMedGoogle Scholar
  45. 45.
    Mayes T, Gottschlich M, Carman B, et al (2005) An evaluation of the safety and efficacy of an anti-inflammatory, pulmonary enteral formula in the treatment of pediatric burn patients with respiratory failure. Nutr Clin Prac 20: 30–31Google Scholar
  46. 46.
    Theilla M, Singer P, Cohen, DeKeyser F (2007) A diet enriched with eicosapentaenoic acid, gamma-linolenic acid and antioxidants in the incidence of new pressure ulcer formation in critically ill patients with acute lung injury: a randomized, prospective, controlled study. Clin Nutr 26: 752–757PubMedGoogle Scholar
  47. 47.
    Pontes-Arruda A, DeMichele SJ, Seth A, Singer P (2008) The use of an inflammation-modulating diet in patients with acute lung injury and acute respiratory distress syndrome: a meta-analysis of outcome data. JPEN J Parenter Enteral Nutr 32: 596–605CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2009

Authors and Affiliations

  • A. Pontes-Arruda
    • 1
  • S. J. DeMichele
    • 2
  1. 1.Intensive Care Nutrition DepartmentFernandes Tavora HospitalFortaleza, CearaBrazil
  2. 2.Strategic and International R & DAbbott NutritionColumbusUSA

Personalised recommendations